Medicare Test Co-Pays Would Add To Labs’ Overhead; Firms Brace For Impact

Diagnostic testing firms' profitability could suffer along with patient access to care if a laboratory diagnostic co-payment provision is included in pending Medicare reform legislation, stakeholders say

More from Archive

More from Medtech Insight